Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Early Assessment of Lymphoma Therapeutic Efficacy Via a Blood-Based Multi-Omics Test

Xinhua Wang, Zhiming Li, Yu Chang, Shiyong Li, Wei Wu, Fangyuan Chang, Yinyin Chang, Dandan Zhu, Mingzhi Zhang, Mao Mao

Blood (2024) 144 (Supplement 1): 4987.

https://doi.org/10.1182/blood-2024-202715

Published: 2024

Journal Articles

The Association between Combination-Based Immunotherapy and Thrombotic Events in Patients with Metastatic Renal Cell Carcinoma

Yu-Cheng Chang, Cho-Han Chiang, Tenzin Tamdin, Junmin Song, Yu Chang, Kuan-Yu Chi, Chun-Yu Peng, Wenli Gao

Blood (2024) 144 (Supplement 1): 2634.

https://doi.org/10.1182/blood-2024-206365

Published: 2024

Journal Articles

Comparative Venous and Arterial Thromboembolism Profiles Associated with Different Cyclin-Dependent Kinase 4/6 Inhibitors: A Real-World Study

Cho Han Chiang, Shuwen Lin, Yu-Cheng Chang, Junmin Song, Kuan-Yu Chi, Nutchapon Xanthavanij, Yu Chang, Cho-Hung Chiang, Xiaocao Haze Xu

Blood (2024) 144 (Supplement 1): 5084.

https://doi.org/10.1182/blood-2024-209023

Published: 2024

Journal Articles

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Blood (2024) 144 (Supplement 1): 6458.

https://doi.org/10.1182/blood-2024-202107

Published: 2024

Journal Articles

Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors - a Real-World Validation

Junmin Song, Yu-Cheng Chang, Ana Maria Diaz Abram, Jaeun Ahn, Kuan-Yu Chi, Yu Chang, Cho-Han Chiang

Blood (2024) 144 (Supplement 1): 5582.

https://doi.org/10.1182/blood-2024-212175

Published: 2024

Journal Articles

The Association between Glucagon-like Peptide-1 Receptor Agonist and Major Adverse Cardiac and Cerebrovascular Events in Monoclonal Gammopathy of Undetermined Significance: A Propensity-Score Analysis

Junmin Song, Shweta Ravindra Deshpande, Yu-Cheng Chang, Cho-Han Chiang, Jaeun Ahn, Ana Yasmin Caceres Lessa, Anushri Soni, Anthony Gonzales, Pei-Lun Lee, Yu Chang, Terri L. Parker, Jennifer Kwan, Kuan-Yu Chi, Michael G. Nanna

Blood (2024) 144 (Supplement 1): 6869.

https://doi.org/10.1182/blood-2024-194867

Published: 2024

Journal Articles

Real-World Validation of the Khorana Risk Score in Predicting Thrombosis for Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Junmin Song, Yu-Cheng Chang, Jaeun Ahn, Kuan-Yu Chi, Yu Chang, Cho-Han Chiang

Blood (2024) 144 (Supplement 1): 4020.

https://doi.org/10.1182/blood-2024-206928

Published: 2024

Journal Articles

Anticoagulation for Patients with Essential Thrombocythemia or Polycythemia Vera-Associated Venous Thromboembolism

Tenzin Tamdin, Yu-Cheng Chang, Cho-Han Chiang, Junmin Song, Kuan-Yu Chi, Yu Chang, Chun-Yu Peng, Wenli Gao

Blood (2024) 144 (Supplement 1): 4014.

https://doi.org/10.1182/blood-2024-206459

Published: 2024

Journal Articles

Comparative Outcomes of Immune Checkpoint Inhibitor and Chemotherapy in Lung Cancer Patients: A Multi-Ethnic Retrospective Analysis

Tenzin Tamdin, Cho-Han Chiang, Junmin Song, Yu Chang, Kuan-Yu Chi, Chun-Yu Peng, Yu-Cheng Chang

Blood (2024) 144 (Supplement 1): 5565.

https://doi.org/10.1182/blood-2024-206535

Published: 2024

Journal Articles

Identifying Inflammatory Pathways That Promote RBC Alloimmunization in Patients with Sickle Cell Disease

Rosario Hernandez-Armengol, June Young Lee, Kausik Paul, Che-Yu Chang, Tomohiro Shibata, David R Gibb

Blood (2023) 142 (Supplement 1): 2663.

https://doi.org/10.1182/blood-2023-190681

Published: 2023

Journal Articles

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue

Blood (2023) 142 (Supplement 1): 1690.

https://doi.org/10.1182/blood-2023-188245

Published: 2023

Journal Articles

Prompt Assessment of Tumor Load and Treatment Response in Patients with Lymphoma By a Blood-Based Multi-Omics Approach

Xinhua Wang, Zhiming Li, Yu Chang, Shiyong Li, Wei Wu, Fangyuan Chang, Yinyin Chang, Dandan Zhu, Mingzhi Zhang, Mao Mao

Blood (2022) 140 (Supplement 1): 6415–6416.

https://doi.org/10.1182/blood-2022-165642

Published: 2022

Journal Articles

The Impact of the Immunophenotyping Characteristics of Patients' Peripheral Blood on the Manufacturing and Clinical Outcome of CD7-Targeted Chimeric Antigen Receptor T Cells

Blood (2021) 138 (Supplement 1): 3830.

https://doi.org/10.1182/blood-2021-147632

Published: 2021

Journal Articles

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Blood (2021) 138 (Supplement 1): 3829.

https://doi.org/10.1182/blood-2021-149999

Published: 2021

Journal Articles

Integrating Circulating Tumor DNA Features and Plasma Protein Markers to Detected Early Lymphoid Neoplasm

Xinhua Wang, Yu Chang, Dandan Zhu, Shiyong Li, Shuaipeng Geng, Yinyin Chang, Yan Chen, Mao Mao, Mingzhi Zhang

Blood (2021) 138 (Supplement 1): 4489.

https://doi.org/10.1182/blood-2021-145683

Published: 2021

Journal Articles

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Lei Zhang, Xiyang Liu, Xinhua Wang, Yu Chang, Xiaorui Fu, Xin Li, Ling Li, Jiaqin Yan, Feifei Nan, Xiaolong Wu, Linan Zhu, Zhenchang Sun, Hui Yu, Mingzhi Zhang

Blood (2021) 138 (Supplement 1): 1368.

https://doi.org/10.1182/blood-2021-152020

Published: 2021

Journal Articles

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139623

Published: 2020

Journal Articles

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139766

Published: 2020

Journal Articles

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-137449

Published: 2020

Journal Articles

Single-Cell Transcriptomic Profiling of De Novo and Relapsed Acute Myeloid Leukemia Identifies a Leukemic Stemness Program Shared across Diverse Phenotypes

Samantha Worme, BSc, Selin Jessa, BSc, William Poon, BSc, Maja Jankovic, MSc, Gabriela Galicia Vazquez, PhD, Alexandre Bazinet, MD, Katharine Fooks, BSc, Isabella Iasenza, BSc, Patricia Arreba-Tutusaus, PhD, Kolja Eppert, PhD, Ioannis Ragoussis, PhD, Yu Chang Wang, PhD, Nathalie A Johnson, MD PhD, Sarit E Assouline, MD MSc, Claudia L Kleinman, PhD, François E Mercier, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-143221

Published: 2020

NARROW

Early Assessment of Lymphoma Therapeutic Efficacy Via a Blood-Based Multi-Omics Test

The Association between Combination-Based Immunotherapy and Thrombotic Events in Patients with Metastatic Renal Cell Carcinoma

Comparative Venous and Arterial Thromboembolism Profiles Associated with Different Cyclin-Dependent Kinase 4/6 Inhibitors: A Real-World Study

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors - a Real-World Validation

The Association between Glucagon-like Peptide-1 Receptor Agonist and Major Adverse Cardiac and Cerebrovascular Events in Monoclonal Gammopathy of Undetermined Significance: A Propensity-Score Analysis

Real-World Validation of the Khorana Risk Score in Predicting Thrombosis for Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Anticoagulation for Patients with Essential Thrombocythemia or Polycythemia Vera-Associated Venous Thromboembolism

Comparative Outcomes of Immune Checkpoint Inhibitor and Chemotherapy in Lung Cancer Patients: A Multi-Ethnic Retrospective Analysis

Identifying Inflammatory Pathways That Promote RBC Alloimmunization in Patients with Sickle Cell Disease

Prompt Assessment of Tumor Load and Treatment Response in Patients with Lymphoma By a Blood-Based Multi-Omics Approach

The Impact of the Immunophenotyping Characteristics of Patients' Peripheral Blood on the Manufacturing and Clinical Outcome of CD7-Targeted Chimeric Antigen Receptor T Cells

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Integrating Circulating Tumor DNA Features and Plasma Protein Markers to Detected Early Lymphoid Neoplasm

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Single-Cell Transcriptomic Profiling of De Novo and Relapsed Acute Myeloid Leukemia Identifies a Leukemic Stemness Program Shared across Diverse Phenotypes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only